XML 50 R39.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT REPORTING (Tables)
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table presents a summary of the revenues and Adjusted EBITDA of our two operating segments for the three and nine months ended September 30, 2025 and 2024:
Three Months Ended September 30,Nine Months Ended September 30,
(In thousands)2025202420252024
Revenues:
Financial Health$54,501 $54,672 $164,918 $162,620 
Patient Care31,605 30,028 94,125 91,796 
Total revenues86,106 84,700 259,043 254,416 
Less:
Financial Health expenses:
Cost of revenues (excluding amortization and depreciation and stock compensation expense)$29,208 $29,077 $85,123 $88,762 
Product development (excluding stock compensation)3,249 1,888 9,360 6,219 
Sales and marketing (excluding stock compensation)3,466 3,664 12,326 12,959 
General and administrative expenses (excluding stock compensation)9,706 10,079 30,865 29,710 
Total Financial Health expenses$45,629 $44,708 $137,674 $137,650 
Patient Care expenses:
Cost of revenues (excluding amortization and depreciation and stock compensation expense)$12,538 $13,069 $36,569 $38,220 
Product development (excluding stock compensation)4,676 5,616 14,474 19,712 
Sales and marketing (excluding stock compensation)1,990 2,067 6,169 6,830 
General and administrative expenses (excluding stock compensation)5,001 4,548 15,912 13,544 
Total Patient Care expenses$24,205 $25,300 $73,124 $78,306 
Total segment expenses$69,834 $70,008 $210,798 $215,956 
Adjusted EBITDA by segment:
Financial Health8,872 9,964 27,244 24,970 
Patient Care7,400 4,728 21,001 13,490 
Total Adjusted EBITDA$16,272 $14,692 $48,245 $38,460 
Schedule of Reconciliation of Adjusted EBITDA to Income (Loss) Before Taxes
The following table reconciles Adjusted EBITDA to income (loss) before taxes:
Three Months Ended September 30,Nine Months Ended September 30,
(In thousands)2025202420252024
Total Adjusted EBITDA$16,272 $14,692 $48,245 $38,460 
Less:
Interest expense and other income2,716 3,777 9,057 11,826 
Depreciation expense243 279 846 1,079 
Amortization of software development costs3,441 3,057 9,757 11,779 
Amortization of acquisition-related intangibles3,046 3,126 9,144 9,379 
Stock-based compensation1,788 1,398 5,098 3,698 
Severance and other non-recurring charges3,686 4,018 7,545 12,449 
Change in fair value of contingent consideration— (1,044)— (1,044)
Loss (gain) on disposal of property and equipment— 1,648 (120)1,648 
Loss (gain) on sale of AHT— 28 (53)(1,221)
Income (loss) before taxes$1,352 $(1,595)$6,971 $(11,133)